The mosquito Aedes aegypti is a potent vector of the Chikungunya, yellow fever, and 2 Dengue viruses, which result in hundreds of millions of infections and over 50,000 human 3 deaths per year. Loss-of-function mutagenesis in Ae. aegypti has been established 4 with TALENs, ZFNs, and homing endonucleases, which require the engineering of 5 DNA-binding protein domains to generate target specificity for a particular stretch of 6 genomic DNA. Here, we describe the first use of the CRISPR-Cas9 system to generate 7 targeted, site-specific mutations in Ae. aegypti. CRISPR-Cas9 relies on RNA-DNA base-8 pairing to generate targeting specificity, resulting in cheaper, faster, and more flexible 9 genome-editing reagents. We investigate the efficiency of reagent concentrations and 10 compositions, demonstrate the ability of CRISPR-Cas9 to generate several different 11 types of mutations via disparate repair mechanisms, and show that stable germ-line 12 mutations can be readily generated at the vast majority of genomic loci tested. This 13 work offers a detailed exploration into the optimal use of CRISPR-Cas9 in Ae. aegypti 14 that should be applicable to non-model organisms previously out of reach of genetic 15 modification. 16 [2, 11, 12], TAL-effector nucleases (TALENS) [13, 14], and homing endonuclease genes 41 (HEGs) [15]. ZFNs and TALENs are modular DNA-binding proteins tethered to a non-42 specific FokI DNA nuclease [16], while HEGs are naturally occurring endonucleases 43 that can be reengineered to target novel sequences [17]. Targeting specificity in these 44 classes of genome-engineering reagents is conferred by context-sensitive protein-DNA 45 binding interactions that are not completely understood. It is therefore technically difficult 46 to engineer these proteins to target many sequences of interest. 47 48 RNA-guided endonucleases (RGENs) based on the type II CRISPR-Cas9 system. RNA-49 DNA Watson-Crick base pairing is used to target the double-stranded endonuclease 50 Cas9, derived from Streptococcus pyogenes, to specific genome locations where it 51 introduces a double-stranded break. In just two years, the CRISPR-Cas9 system has 52 been adapted for precision genome-engineering in dozens of model organisms from 53 bacteria to primates [3, 18]. While many of these efforts have influenced our work, two 54 studies in the vinegar fly Drosophila melanogaster [19] and the zebrafish Danio rerio [20] 55
Introduction

17
As a primary vector of the serious and sometimes fatal Chikungunya, yellow and Dengue 18 viruses, the mosquito Aedes aegypti (Ae. aegypti) is responsible for hundreds of millions 19 of human infections annually [1] . To transmit disease, a female mosquito must first 20 bite an infected individual, and, after a period of viral incubation within the mosquito, 21 bite another human. Female mosquitoes use cues such as odor, carbon dioxide, and 22 temperature to locate a host and obtain a blood-meal [2] , used to produce a clutch 23 of approximately 100 eggs. Once a mosquito has developed mature eggs, she uses 24 volatile and contact cues to locate and evaluate a body of water at which to lay her eggs, 25 or oviposit. Our long-term goals involve using genome-engineering techniques coupled 26 with quantitative behavioral analysis to investigate the genetic and neural basis of innate 27 chemosensory behaviors in this important disease vector. 28 Clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR asso-29 ciated (Cas) genes are components of an adaptive immune system that are found in 30 a wide variety of bacteria and archaea [3] . Beginning in late 2012 [4] , the bacterial 31 type II CRISPR-Cas9 system has been adapted as a genome-engineering tool in a 32 wide variety of organisms and in vitro preparations, dramatically expanding the ability to 33 introduce specific genome modifications [3] . In particular, the ease of designing and 34 generating these reagents at the bench has opened the door for studies of gene function 35 in non-traditional model organisms. 36 The genome of Ae. aegypti is relatively large and incompletely mapped [5] [6] [7] [8] , 37 presenting difficulties in recovering mutations generated by traditional forward genetics. 38 Ae. aegypti has a recent history of genetic modification, including transposon-mediated 39 transgenesis [9, 10] and loss-of-function gene editing with zinc-finger nucleases (ZFNs) 40 In this paper, we describe methods for site-directed mutagenesis in Ae. aegypti using sgRNA design and construction 85 sgRNAs were designed by manually searching genomic regions for the presence of 86 protospacer-adjacent motifs (PAMs) with the sequence NGG, where N is any nucleotide. 87 We required that sgRNA sequences be 17-20 bp in length, excluding the PAM, and 88 contain one or two 5' terminal guanines to facilitate transcription by T7 RNA polymerase. 89 sgRNA sequences were checked for potential off-target binding using the following 90 two web tools: http://zifit.partners.org/ZiFiT/ and http://crispr.mit.edu. To 91 minimize the potential for off-target mutagenesis, we avoided sgRNA sequences with 92 closely related binding sites, defined as fewer than 3 mismatched bases to reduce the 93 possibility of cutting, whenever possible. See Table 1 for sgRNA sequences and closest 94 matches. 95 Linear double-stranded DNA templates for specific sgRNAs were produced by a 96 template-free polymerase chain reaction (PCR) with two partially overlapping oligos 97 (primers sgRNA-R and sgRNA-F; Table 2 ) [19] . In early experiments, sgRNA sequences 98 were cloned into pDR274 [20] and linearized with PmeI (R0560, NEB). In both cases 99 sgRNAs were produced using the MegaScript T7 in vitro transcription kit (AM1334, 140 To verify the presence of exogenous sequences inserted by homology-directed-repair or 141 the presence of insertions and deletions, PCR amplicons surrounding the putative cut 142 site were generated from genomic DNA (see Table 2 for primer sequences). Following 143 purification, amplicons were Sanger sequenced (Genewiz), or used as a template for 144 a restriction digest using the enzyme BamHI (R0136, New England Biolabs [NEB]) or 145 PacI (R0547, NEB). 146 Genotyping stable germ line alleles by fluorescence 147 Larvae or pupae were immobilized on a piece of moist filter paper and examined under 148 a dissection microscope (SMZ1500, Nikon) with a fluorescent light source and ECFP 149 and dsRed filtersets. 150 
Molecular genotyping of stable germ line alleles by PCR
Results
151
Outline of CRISPR and injection components 152 The bacterial type-II CRISPR system has been adapted in many organisms to generate 153 RNA-guided endonucleases, or RGENs, that are targeted to specific regions of the 154 genome by RNA-DNA base-pairing [3] . The core of this adapted CRISPR/Cas system 155 is comprised of two components: 1) a synthetic single guide RNA (sgRNA), which is a 156 small RNA containing 17-20 bases of complementarity to a specific genomic sequence, 157 and 2) the Cas9 nuclease derived from Streptococcus pyogenes (SpCas9). SpCas9 158 forms a complex with the sgRNA and induces double-stranded DNA breaks at regions 159 of the genome that fulfill two criteria: 1) contain a sequence complementary to the 160 recognition site of the sgRNA that is 2) directly adjacent to a protospacer-adjacent motif 161 (PAM). The PAM sequence for SpCas9 takes the form of NGG. These motifs occur 162 approximately once every 17 bp in the Ae. aegypti genome, making it possible to target 163 essentially any genomic loci of interest with the CRISPR-Cas9 system. 164 To generate stable mutations that can be transmitted through the germline, CRISPR-165 Cas9 reagents must be introduced pre-blastoderm stage embryos composed of a 166 syncytium of nuclei prior to cellularization ( Figure 1 ). This early developmental stage 167 offers access of genome-editing reagents to the nuclei of both somatic and germ-line 168 cells. In brief, embryos are microinjected 4-8 hours after egg-laying, and allowed to 169 develop for 3 days before being hatched in a deoxygenated hatching solution [21] . 170 Following hatching, pupae are collected for sequencing or allowed to emerge as adults 171 and outcrossed to wild-type LVP-IB12 males or females, as appropriate. Genomic DNA 172 from injected embryos is examined for modification rates. Following blood-feeding, G 1 173 eggs are collected from these outcrosses to screen for germ-line transmission of stable 174 mutations. 175 When faced with a double-stranded DNA break, DNA repair machinery can resolve 176 this break in one of two ways: non-homologous end-joining, which can result in small 177 insertions and deletions, or, less frequently, homology-directed repair, which uses 178 exogenous sequence containing regions of homology surrounding the cut site as a 179 template for repair. Additionally, cutting with multiple sgRNAs can result in large deletions 180 between the two cut sites. In this paper, we will discuss stable germ-line transmission of 181 all three types of these alleles in Ae. aegypti.
182
Identifying optimal injection mixes for CRISPR-Cas9 mutagenesis 183 The insertions and deletions resulting from non-homologous end-joining act as a signa-184 ture for evaluating the efficiency of reagents such as ZFNs, TALENs, and CRISPR-Cas9. 185 Quantifying the level of these insertions and deletions can give an indication of the to false positives from polymorphisms present in our wild-type strains. 197 For these reasons, we opted to prepare and deep sequence barcoded cons surrounding putative CRISPR-Cas9 cut sites from small pools of injected animals 199 to accurately determine the rates of cutting at different genomic loci. Briefly, sequencing 200 libraries are prepared using a two-step PCR process that incorporates adapter and 201 barcode sequences necessary for Illumina sequencing (Figure 2A ). Many distinct bar-202 coded amplicons can be pooled together using Illumina-supplied Nextera XT primers. 203 We estimate that 10,000-100,000 reads are ample for this analysis, meaning that at 204 current prices, sequencing of amplicons from 3 sgRNAs per gene, for 10 distinct genes 205 can be run for a cost of approximately $70 per gene (MiSeq v3 reagents, 150-cycle 206 flowcell, item MS-102-3001).
207
Following sequencing, reads were aligned to a reference sequence using the GSNAP 208 short read aligner [23] , and insertions and deletions were quantified using the python 209 package pysamstats. This procedure results in data on the number of polymorphisms, 210 including insertions and deletions, found in reads that span each nucleotide of a ref- 211 erence sequence ( Figure 2B ). Notably, in injections containing a sgRNA and Cas9, 212 a pattern of elevated insertions and deletions can be observed with a peak 3 bp 5' 213 of the beginning of the PAM, exactly the position at which Cas9 is known to make a 214 double-stranded break ( Figure 2C ). Importantly, there was high concordance in the 215 mutagenesis rates seen between multiple biological replicates generated from different 216 pools of pupae from a single injection ( Figure 2C ), suggesting that there is minimal 217 variability in mutagenesis frequency in individual injected animals. 218 We next varied the delivery method and concentration of Cas9 and the concentration 219 of a given sgRNA to determine an optimal injection mix composition that would yield high 220 levels of somatic and germline mutations. We first attempted mutagenesis with plasmid 221 DNA constructed to express Cas9 under the control of an Ae. aegypti polyubiquitin 222 (PUb) promoter that can effectively drive TALEN half-sites when microinjected into 223 embryos [13, 29] . However, injection mixes containing PUb-Cas9 plasmid and a validated 224 sgRNA did not induce detectable rates of insertions or deletions (data not shown). 225 The failure of Cas9 expressed by plasmid DNA might be due to the temporal 226 dynamics of transcription and translation, so we explored two additional methods of Figure 2D ). To test 231 whether the concentration of sgRNA or Cas9 mRNA or protein was limiting in these 232 earlier injections, we tried four additional injection mixes ( Figure 2E) , with a single 233 validated sgRNA, and determined that mixes containing 400 ng/µL Cas9 recombinant 234 protein induced the highest rates of mutagenesis. Increasing sgRNA concentration did 235 not dramatically increase mutagenesis rates.
236
Identifying active sgRNAs for a given genomic target 237 We reasoned that sgRNAs that show higher somatic cut rates in injected animals would 238 be more likely to result in stable germ-line transformation. We first designed 3 different 239 sgRNAs against 6 different genes using publicly-accessible design tools to minimize the 240 potential for off-target mutagenesis ( Figure 3A ). These varied in length between 17-20 241 bp [30] , and in addition to being adjacent to a PAM sequence, were required to begin 242 with GG or G to facilitate in vitro transcription of sgRNA. 243 To test the efficiency of these sgRNAs, we performed a series of 6 small test 244 injections (145-168 embryos each) into Ae. aegypti embryos ( Figure 3B ). Each injection 245 mix was comprised of recombinant Cas9 protein at 333 ng/µL and a pool of three 246 sgRNAs (40 ng/µL each), each targeted against a different gene. Survival rates were 247 very high for these injections (ranging from 46.1%-63.3%, as compared to a 18.6% 248 average survival in previous experiments with 500 ng/µL Cas9 protein or mRNA), and 249 we attribute this marked increase in survival to the reduction in Cas9 (or overall injection 250 mix) concentration. Surviving embryos were reared to pupal stages and collected for 251 PCR amplicon preparation and sequencing analysis ( Figure 3B ). 252 All 18 sgRNAs induced detectable levels of mutagenesis, although the rates of 253 cutting were highly variable within and between different genomic targets ( Figure 3C ). 254 Thus, in addition to potential effects of chromatin state or other genome accessibility at 255 a particular genomic locus, there appear to be sequence-or context-dependent effects 256 on sgRNA efficiency that are not yet fully understood. Designing and testing 3 sgRNAs 257 resulted in the identification of at least one highly active sgRNA for the 6 genomic targets 258 tested here. The variability observed between different sgRNAs targeting the same 259 locus underscores the benefits of testing multiple sgRNAs per gene before undertaking 260 large-scale mutagenesis injections. 262 We next examined whether somatic mutagenesis detected in adults reared from injected 263 embryos (G 0 animals) could result in transmission of stable mutant alleles through the 264 germline to their offspring (G 1 animals). We designed an sgRNA near the 5' end of Figure 4A ). 273 636 embryos were injected with a mixture of 200 ng/µL Cas9 mRNA and 12.5 ng/µL 274 sgRNA. Note that these injections were performed prior to the optimization of injection 275 mixes described above. To determine the activity of our injected reagents, we performed 276 amplicon sequencing on 6 pools of 5-6 adult G 0 animals after they were outcrossed 277 and allowed to lay eggs ( Figure 4B ). After alignment and analysis of reads aligning to 278 the reference sequence, we found that these samples contained a mean maximum 279 somatic insertion or deletion rate of 24.87% centered on the Cas9 cut site ( Figure 4C ), 280 indicating a high rate of somatic mosaicism at the targeted locus in animals injected 281 with this cocktail. As a control, we sequenced amplicons at the Aaeg-wtrw locus from 282 animals injected with an injection mix containing another sgRNA targeting a different 283 region of the genome. These samples contained no detectable insertions or deletions 284 at the Aaeg-wtrw locus ( Figure 4C ). Across the six samples, a mean of 0.71% of reads 285 that aligned to the reference sequence contained sequences corresponding to the 286 exogenous sequence in the single-stranded DNA donor ( Figure 4D ). This indicated that 287 the ssODN template could drive homology-directed repair in somatic tissue, though 288 at a much lower frequency than insertions or deletions mediated by non-homologous 289 end-joining. 290 To determine whether these mutations were stably transmitted through the germline, 291 we sequenced PCR amplicons derived from pools each containing 5 male and 5 female 292 G 1 offspring that were previously mated together and from which we had already 293 collected F2 eggs. Analysis of resulting insertions and deletions using Genome Analysis 294 Toolkit [GATK; [24] ] revealed that there were at least 117 mutant chromosomes spread 295 across 50 pools, meaning that the G 1 mutation rate was at least 117/620, or 18.9% 296 ( Figure 4E ). Four of these alleles corresponded perfectly to the sequence of the ssODN, 297 meaning that our rate of stable germline transmission of alleles generated by homology-298 driven repair recombination is at least 0.6% ( Figure 4E ). Notably, these numbers 299 correlate well with those derived from G 0 animals ( Figure 4E ), suggesting that assays of 300 somatic mutagenesis can be useful in predicting the efficiency of germ-line mutagenesis. 301 We hatched F2 eggs from a single family containing an allele generated by homology-302 directed repair. Sequencing of single-pair crosses allowed us to isolate a stable mutant 303 line that can be genotyped by a simple restriction digest with the enzyme site introduced 304 by the ssODN targeting event ( Figure 4F ). To enable future phenotypic characterization, 305 this line was outcrossed for 8 generations to wild-type mosquitoes to increase genetic 306 diversity in the mutant strain and to reduce the possibility of retaining off-target mutations 307 in this population of animals.
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Germ-line transmission of mutant alleles
308
Deletions induced by multiplexed sgRNAs 309 Double-stranded breaks induced at multiple sgRNA sites can induce large deletions 310 between the two cut sites in D. melanogaster [32] . We performed a series of five 311 injections into small numbers of embryos using sgRNAs targeting 3 different genes. 312 All but one of these sgRNAs (AAEL000926-sgRNA4) were previously validated as 313 having high activity in somatic mutagenesis assays. We also included ssODN donors 314 with arms on either side of the two breaks and an exogenous sequence containing 315 stop codons in all 3 frames of translation as well as a restriction enzyme recognition 316 site ( Figure 5A ). We injected small numbers of embryos and collected G 1 embryos 317 from all female G 0 animals, which were hatched and screened individually ( Figure 5B ). 318 From these individual families, we screened male pupae in pools via PCR, identifying 319 potential mutations through size-based genotyping on an agarose gel. Individual females 320 were outcrossed, blood-fed, and allowed to lay eggs. PCR amplicons were generated 321 from these animals individually and examined for size-shifted bands on agarose gels 322 ( Figure 5C ). Candidate alleles were characterized by Sanger sequencing of gel-purified 323 fragments ( Figure 5C ). We found a wide range of mutant transmission rates in female 324 G 1 animals derived from single G 0 individuals where genotyping male pupae showed 325 the offspring of these G 0 animals to contain at least one mutant G 1 ( Figure 5D ). 326 Although we did not fully characterize each potential mutant allele, we did note 327 several different types of mutations in those that were characterized. These ranged 328 from simple deletions, to homology-directed repair from the ssODN donor, to more 329 complex modifications, including polymorphisms, inversions, and duplications. This 330 indicates that induction of multiple double-stranded breaks is highly mutagenic. We 331 also note that we were successful in obtaining germ-line mutations at high rates in 332 all 3 injections ( Figure 5E ), making this a cost-effective and efficient way to generate 333 loss-of-function mutant alleles. The relatively large size of deletions generated by this 334 method makes sized-based molecular genotyping straightforward and greatly facilitates 335 the out-crossing and homozygosing of mutant lines.
336
Integration and transmission of large fluorescent cassettes 337 Finally, we asked whether CRISPR-Cas9 could be used to introduce longer cassettes of 338 exogenous sequence via homology-dependent repair. In previous genome-engineering 339 experiments in Ae. aegypti, zinc-finger nucleases were used to introduce large cassettes 340 from a plasmid DNA donor with homology arms of at least 800 bp on either side 341 [2, 11] . The insertion of a fluorescent cassette simultaneously creates a null mutant by 342 interrupting the protein-coding sequence and inserts the visible fluorescent reporter. 343 We performed injections with Cas9 protein, a validated sgRNA, and a plasmid donor Figure 6E ). 372 We generated verified targeted insertions in two genomic loci with the Ae. aegypti Figure 6 ). 383 Taken together, these data show that the CRISPR-Cas9 system can be been suc-384 cessfully adapted for genome-engineering in the mosquito Ae. aegypti. Following the 385 generation of a double-stranded break by an RNA-guided Cas9 nuclease, a variety of 386 mutant alleles can be recovered, including frame-shift mutations caused by insertions 387 or deletions, deletion of a region between two sgRNA target sites, and integration of 388 exogenous sequences from a single-stranded oligonucleotide or a double-stranded plas-389 mid DNA donor. We recommend these methods to any laboratory wishing to generate 390 loss-of-function mutations in Ae. aegypti. 392 We have demonstrated that the CRISPR-Cas9 system is a highly effective and efficient 393 tool for precision genome-editing in the mosquito Ae. aegypti. Compared to the relatively 394 low throughput and high cost of ZFN-and TALEN-mediated mutagenesis, the ease and 395 efficiency of designing and producing CRISPR-Cas9 reagents in the laboratory has 396 allowed us to generate stable and precise loss-of-function mutations in over 10 genes to 397 date. This protocol provides a step-by-step manual to mutagenesis in Ae. aegypti and 398 also provides general principles that will be useful when translated to other species.
391
Discussion and Conclusions
399
Optimal injection mix 400 We recommend using recombinant Cas9 protein for its reproducibility and observed 401 increased rates of mutagenesis and embryo survival. Recombinant Cas9 protein is 402 likely to be much more stable than mRNA, both at the bench and in injected embryos. 403 Additionally, it is likely that sgRNA and Cas9 protein can form a complex in the absence 404 of any other factors, allowing them to generate pre-formed RGENs prior to injection. This 405 can serve to both stabilize sgRNA/Cas9 complexes [33] and ensure that mutagenesis 406 can occur immediately, rather than waiting for Cas9 mRNA to be translated in the embryo. 407 The specific concentrations suggested here represent a good trade-off between survival 408 and efficiency in our hands. However, it is entirely possible that further modifications to 409 this protocol could result in significant increases in certain types of repair. 419 We observed significant variability in the effectiveness of different sgRNAs, even be-420 tween sgRNAs targeted to a small genomic region (Figure 3 ). As in other organisms 421 and cell lines [30, 34] , we observed success with sgRNAs ranging in length from 17-20 422 bp, and recommend considering sgRNAs in this size range when screening for the 423 most active target sites. A single genomic target (AAEL001123) has proven resistant 424 to mutagenesis with 6 different sgRNAs, perhaps reflecting an underlying chromatin-425 state [35] . Aside from this one example, we were able to design effective sgRNAs to all 426 other examined genes. Systematic examination of sgRNA efficiency in D. melanogaster 427 suggests that the GC content of the 6 nucleotides adjacent to the PAM contributes to 428 the efficiency of a given sgRNA [34] . We will incorporate these suggestions as well as 429 those generated from further investigations into the sequence or context-dependency 430 of sgRNA activity into our future sgRNA design. However, given the ease of testing 431 sgRNA efficiency in vivo, we still recommend the design and testing of multiple sgRNAs 432 targeting a given gene before committing to large-scale injections.
433
Off-target effects 434 Off-target effects are a concern with any genome-editing technology. We currently adopt 435 several approaches to try and address these concerns in our experiments. First, we 436 check for the sgRNA specificity using publicly available bioinformatic tools [20, 36, 37] , 437 selecting the most specific sgRNAs within the region we wish to target. Second, we 438 design several sgRNAs for a given genomic target. For genes of particular interest, 439 we can generate mutant alleles with multiple sgRNAs and examine their phenotype in 440 transallelic combination, reducing the likelihood that these independent lines will share 441 the same off-target mutations. Third, we have successfully used truncated sgRNAs of 442 less than 20 bp in length, which have been shown in cell culture to reduce the likelihood 443 of off-target modifications [30] . Finally, we subject all lines to at least 8 generations of 444 out-crossing to wild-type mosquitoes, which should reduce the co-inheritance of all but 445 the most tightly linked off-target mutations. While we believe these guidelines reduce 446 the likelihood of significant levels of off-target mutagenesis, we recognize the need 447 for continued efforts to improve and to verify the specificity of all precision genome-448 engineering technologies. 449 Variants on the traditional CRISPR-Cas9 reagents designed to improve specificity 450 include the use of paired Cas9 'nickases' to generate adjacent single-stranded DNA 451 breaks [38] [39] [40] [41] . These dual 'nicks' are proposed to be less mutagenic than a single 452 double-stranded break. This approach should decrease the chance that the binding 453 of a single sgRNA at an off-target site produces a mutation. Another approach fuses 454 a nuclease-dead Cas9 mutant (dCas9) to the FokI nuclease. As in ZFN and TALENs, 455 FokI requires paired binding, within a certain distance, on opposite strands of a target, 456 and this technique aims to combine the specificity of TALENs and ZFNs with the 457 ease-of-targeting of CRISPR-Cas9 [42, 43] . Though we have not investigated these 458 CRISPR-Cas9 variants in our experiments, we believe that their benefits are likely to 459 translate to Ae. aegypti and other organisms in the future.
460
Enhancing the efficiency of homology-directed repair 461 In our experiments, insertions and deletions mediated by non-homologous end-joining 462 occur at much higher frequency than by homology-directed repair. This is similar to what 463 has been observed in Ae. aegypti with other genome-editing tools, such as ZFNs [2, 11] , 464 and in other organisms such as D. melanogaster [44] . 465 Several approaches have been developed to increase rates of homology-directed 466 repair. These include injections in the background of a DNA ligase 4 mutation [45, 46] homology-independent double-stranded break repair pathways [48] . It remains to be 473 seen whether transgenic Cas9 delivery or alternative integration approaches can be 474 effectively implemented in Ae. aegypti. 475 We note that we have observed a single round of injection that resulted in high 476 (>30%) rates of homology-directed repair but extremely low survival ( Figure 7A ). This 477 suggests that we might achieve improvements in insertion efficiency by continuing to 478 examine the effects of modulating the concentrations of the three components of the 479 injection mix. If the rates of homology-directed-repair can be sufficiently improved, 480 CRISPR-Cas9 coupled with transgene insertion via homology-directed repair will likely 481 prove to be a versatile tool to tag gene products and introduce transgenes into specific 482 genomic loci, enabling studies of specific neural circuits and other subsets of cells.
483
Conclusions
484
Precision genome-engineering in mosquitoes holds great promise for studies on the 485 genetic basis of behavior [2, 11, 12] and for genetic strategies to control vector population 486 or disease competence [49] . Ongoing efforts to increase the specificity and efficiency of 487 these technologies is critical to their adaptation as routine techniques, and we believe 488 that the protocols outlined here have met those criteria for the generation of loss-of-489 function mutations in the mosquito Ae. aegypti. Reagents based on the CRISPR-Cas9 490 platform have been used successfully in organisms from bacteria to primates. This 491 suggests that the techniques described here can likely be adapted to many other non-492 model organisms, so long as efficient methods of introducing the reagents into the 493 germline and screening for mutations can be developed. Table 1 . Sequences of sgRNAs used in this study. Potential off-target sites were evaluated by two publicly available tools. ZiFiT (http://zifit.partners.org) was used to determine the number of potential off-target sites in the Ae. aegypti genome with 3 or fewer mismatched bases (mm). The number of distinct sites with the given number of mismatches is noted in parentheses. The CRISPR Design Tool (http://crispr.mit.edu) uses an algorithm to evaluate potential off-target sites in the context of the Ae. aegypti genome and returns a specificity score for sgRNAs of length 20 bp. Scores above 50 are considered "high quality". * indicates sgRNA targets of 17-19bp that cannot be tested with the CRISPR Design Tool 2 . Deep sequencing approach to quantifying CRISPR-Cas9 efficiency A) Schematic of strategy to generate barcoded PCR amplicons for sequencing. In this example (B-C) amplicons were generated from adults reared from embryos injected with Cas9 and an sgRNA (AAEL004091-sgRNA1) using primers AAEL004091-1-F and AAEL004091-1-R. B) Visualization of a subset of alignments to the amplicon reference sequence (top) reveals a heterogeneity of insertions, deletions, and other changes. C) Quantification of three replicate libraries, plotted as a percentage of reads aligned to a given base that contain an insertion or deletion at that base, shows reproducibility of mutation rates between individual pools of pupae derived from the same injection. Data are represented as a percentage of reads aligned to a given base that contain an insertion or deletion at that base, and is plotted as mean (circle) and 95% confidence intervals (line 
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Figure 3. Identifying active sgRNAs A)
Schematic of two target genes in the Ae. aegypti genome: AAEL004091 and AAEL000926. Three sgRNAs were designed against the first 500 bp of each gene. B) Schematic of the workflow for a small injection (approx. 150 embryos) of Cas9 protein and a pool of three sgRNAs against three distinct target genes. After rearing to pupal stages to synchronize developmental time, genomic DNA was extracted and sequencing amplicons were prepared against each of the three targets. C) Sequencing results from 6 small injections (sgRNA sequences can be found in Table 1 ). . Deletions generated by multiple sgRNAs A) Schematic of the AAEL010779 genomic locus detailing the design of two sgRNAs and a ssODN donor. B) Injection strategy to identify deletion events in G 1 animals with the injection of a small (125-150) number of embryos. C) Example agarose gel of 9 G 1 females that are the offspring of a single G 0 female. All individuals contain the wild-type band (black arrowhead). Sanger sequencing verified that the smaller band (red arrowhead) present in 5/9 heterozygous individuals is the result of a clean deletion between the two sgRNA cut sites. D) Plot of the proportion of mutant AAEL010779 G 1 females from the 10 G 0 families identified as containing at least one mutant allele. E) Summary data from 3 injections of this type show high rates of G 1 mutagenesis across all 3 injections. 
